德国全科实践中实施多重用药建议的影响因素:定性研究
本研究基于德国全科实践的多重用药管理建议(结构化用药咨询、用药清单、系统用药审查),通过访谈和焦点小组识别实施障碍与促进因素。共访谈24名全科医生、4名其他专科医生、1名药师、3名护士和6名医疗助理,并开展2个混合焦点小组(17名专业人员),共识别93个决定因素,覆盖TICD清单全部7个主域和25个子域。结论提示改进多重用药需超越药理知识,关注沟通技能、患者参与和实践组织。
要点
- 多重用药管理建议的实施受多域因素影响,涉及指南、患者、医务人员、社会政治法律、激励资源及组织变革能力。
- 结构化用药咨询、用药清单和系统用药审查分别对应29、21、20个决定因素,另有23个因素影响所有建议。
- 改善多重用药的干预不应仅聚焦药理知识,还需关注沟通技能、患者参与和实践组织。
核心结论
- 实施多重用药管理建议需覆盖TICD清单全部7个主域和25个子域,远超出药理知识范畴。
研究设计与样本
- 定性研究,嵌套于德国全科实践的多重用药建议实施干预项目,在干预设计阶段和干预交付后分别开展访谈与焦点小组,内容分析法归纳类别后映射至TICD清单。
主要发现
- 共访谈24名全科医生、4名其他专科医生、1名药师、3名护士和6名医疗助理,并开展2个混合焦点小组共17名专业人员,识别93个决定因素。
- 29个决定因素涉及用药咨询,21个涉及用药清单使用,20个涉及用药审查,23个涉及所有建议。
- 决定因素覆盖TICD清单全部7个主域和57个子域中的25个,包括指南因素、患者因素、医务人员个体因素、社会政治法律因素、激励与资源、组织变革能力。
临床怎么用
- 在全科实践中实施多重用药管理建议时,应系统评估多域障碍与促进因素,而非仅提供药理知识培训。
- 干预设计需纳入沟通技能、患者参与和实践组织等非药理维度。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Key recommendations for the management of patients with polypharmacy are structured medication counselling (SMC), medication lists and systematic medication reviews. OBJECTIVE: The aim of this study was to identify determinants (hindering and facilitating factors) for the implementation of the recommendations in general practice. METHODS: This study was linked to a tailored intervention aimed at improving the implementation of the recommendations in German general practice. Interviews and focus groups with different healthcare professionals were carried out in the design phase and after delivery of the intervention. The material from both data collections was analysed separately in a content analytical approach resulting in two sets of categories. For this study, the subcategories of both sets were assigned to the Tailoring Interventions for Chronic Diseases (TICD) checklist, a comprehensive framework of determinants of practice. RESULTS: Interviews with 24 general practitioners (GPs), 4 other medical specialists, 1 pharmacist, 3 nurses and 6 medical assistants as well as 2 mixed focus groups with 17 professionals were conducted. We identified 93 determinants: 29 referred to medication counselling, 21 to the use of medication lists, 20 to medications reviews and 23 to all recommendations. The determinants were related to all 7 main domains and to 25 of the 57 subdomains on the TICD checklist including guideline factors, patient factors, individual healthcare professional factors, social, political and legal factors, incentives and resources, and capacity for organizational change. CONCLUSION: While many interventions to improve polypharmacy focus on the provision of pharmacological knowledge, a much wider range of domains need to be addressed, such as communication skills, patient involvement and practice organization.
引用
- Straßner C, Steinhäuser J, Freund T, et al. German healthcare professionals' perspective on implementing recommendations about polypharmacy in general practice: a qualitative study. Fam Pract. 2018. PMID: 29267951. doi:10.1093/fampra/cmx127
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。